Exercise Training Restores Cardiac Protein Quality Control in Heart Failure

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Campos, Juliane C ^a   Queliconi, Bruno B ^a   Dourado, Paulo M M ^a   Cunha, Telma F ^a   Zambelli, Vanessa O ^b   Bechara, Luiz R G ^a   Kowaltowski, Alicia J ^a   Brum, Patricia C ^a   Mochly Rosen, Daria ^c   Ferreira, Julio C B ^a,c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO BUTANTAN   (Brazil)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYNONENAL; ANTIMYCIN A1; CITRATE SYNTHASE; HYDROGEN PEROXIDE; PROTEASOME; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIOACCUMULATION; BODY WEIGHT; CALCIUM TRANSPORT; CARDIAC PROTEIN QUALITY CONTROL; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME ACTIVITY; ENZYME INACTIVATION; EXERCISE; EXERCISE TOLERANCE; HEART CELL CULTURE; HEART EJECTION FRACTION; HEART FAILURE; HEART FUNCTION; HEART MITOCHONDRION; HEART MUSCLE OXYGEN CONSUMPTION; HEART WEIGHT; IN VITRO STUDY; IN VIVO STUDY; MALE; MITOCHONDRIAL RESPIRATION; MOLECULAR DYNAMICS; NEWBORN; NONHUMAN; OXIDATIVE STRESS; RAT; REGULATORY MECHANISM;

ALDEHYDES; ANIMALS; CALCIUM; CELLS, CULTURED; EXERCISE THERAPY; HEART FAILURE; HYDROGEN PEROXIDE; MALE; MITOCHONDRIA, HEART; MUSCLE PROTEINS; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOCYTES, CARDIAC; OLIGOPEPTIDES; OXIDATION-REDUCTION; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEASOME INHIBITORS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RATS; RATS, WISTAR; RUNNING;

ANIMALIA; RATTUS;

EID: 84871647669     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052764     Document Type: Article

References (50)

1. Guyatt GH, Devereaux PJ, (2004) A review of heart failure treatment. Mt Sinai J Med 71: 47-54.
2. Emter CA, McCune SA, Sparagna GC, Radin MJ, Moore RL, (2005) Low-intensity exercise training delays onset of decompensated heart failure in spontaneously hypertensive heart failure rats. Am J Physiol Heart Circ Physiol 289: H2030-2038.
3. Powers SK, Lennon SL, Quindry J, Mehta JL, (2002) Exercise and cardioprotection. Curr Opin Cardiol 17: 495-502.
4. Jonsdottir S, Andersen KK, Sigurosson AF, Sigurosson SB, (2006) The effect of physical training in chronic heart failure. Eur J Heart Fail 8: 97-101.
5. Roveda F, Middlekauff HR, Rondon MU, Reis SF, Souza M, et al. (2003) The effects of exercise training on sympathetic neural activation in advanced heart failure: a randomized controlled trial. J Am Coll Cardiol 42: 854-860.
6. Wisloff U, Stoylen A, Loennechen JP, Bruvold M, Rognmo O, et al. (2007) Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients: a randomized study. Circulation 115: 3086-3094.
7. Rosca MG, Hoppel CL, (2010) Mitochondria in heart failure. Cardiovasc Res 88: 40-50.
8. Roede JR, Jones DP, (2010) Reactive species and mitochondrial dysfunction: mechanistic significance of 4-hydroxynonenal. Environ Mol Mutagen 51: 380-390.
9. Bulteau AL, Lundberg KC, Humphries KM, Sadek HA, Szweda PA, et al. (2001) Oxidative modification and inactivation of the proteasome during coronary occlusion/reperfusion. J Biol Chem 276: 30057-30063.
10. Farout L, Mary J, Vinh J, Szweda LI, Friguet B, (2006) Inactivation of the proteasome by 4-hydroxy-2-nonenal is site specific and dependant on 20S proteasome subtypes. Arch Biochem Biophys 453: 135-142.
11. Isom AL, Barnes S, Wilson L, Kirk M, Coward L, et al. (2004) Modification of Cytochrome c by 4-hydroxy- 2-nonenal: evidence for histidine, lysine, and arginine-aldehyde adducts. J Am Soc Mass Spectrom 15: 1136-1147.
12. Maki CG, Huibregtse JM, Howley PM, (1996) In vivo ubiquitination and proteasome-mediated degradation of p53(1). Cancer Res 56: 2649-2654.
13. Salghetti SE, Kim SY, Tansey WP, (1999) Destruction of Myc by ubiquitin-mediated proteolysis: cancer-associated and transforming mutations stabilize Myc. Embo J 18: 717-726.
14. Dimmeler S, Breitschopf K, Haendeler J, Zeiher AM, (1999) Dephosphorylation targets Bcl-2 for ubiquitin-dependent degradation: a link between the apoptosome and the proteasome pathway. J Exp Med 189: 1815-1822.
15. Patterson C, Ike C, Willis PWt, Stouffer GA, Willis MS, (2007) The bitter end: the ubiquitin-proteasome system and cardiac dysfunction. Circulation 115: 1456-1463.
16. Tsukamoto O, Minamino T, Okada K, Shintani Y, Takashima S, et al. (2006) Depression of proteasome activities during the progression of cardiac dysfunction in pressure-overloaded heart of mice. Biochem Biophys Res Commun 340: 1125-1133.
17. Hein S, Arnon E, Kostin S, Schonburg M, Elsasser A, et al. (2003) Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation 107: 984-991.
18. Grune T, Davies KJ, (2003) The proteasomal system and HNE-modified proteins. Mol Aspects Med 24: 195-204.
19. Reinheckel T, Sitte N, Ullrich O, Kuckelkorn U, Davies KJ, et al. (1998) Comparative resistance of the 20S and 26S proteasome to oxidative stress. Biochem J 335 (Pt 3):: 637-642.
20. Johns TN, Olson BJ, (1954) Experimental myocardial infarction. I. A method of coronary occlusion in small animals. Ann Surg 140: 675-682.
21. Gheorghiade M, Bonow RO, (1998) Chronic heart failure in the United States: a manifestation of coronary artery disease. Circulation 97: 282-289.
22. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, et al. (2009) 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 119: e391-479.
23. Ferreira JC, Bacurau AV, Bueno CR Jr, Cunha TC, Tanaka LY, et al. (2010) Aerobic exercise training improves Ca2+ handling and redox status of skeletal muscle in mice. Exp Biol Med (Maywood) 235: 497-505.
24. Myers J, Prakash M, Froelicher V, Do D, Partington S, et al. (2002) Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 346: 793-801.
25. Ferreira JC, Rolim NP, Bartholomeu JB, Gobatto CA, Kokubun E, et al. (2007) Maximal lactate steady state in running mice: effect of exercise training. Clin Exp Pharmacol Physiol 34: 760-765.
26. Ferreira JC, Moreira JB, Campos JC, Pereira MG, Mattos KC, et al. (2011) Angiotensin receptor blockade improves the net balance of cardiac Ca(2+) handling-related proteins in sympathetic hyperactivity-induced heart failure. Life Sci 88: 578-585.
27. Ferreira JC, Bacurau AV, Evangelista FS, Coelho MA, Oliveira EM, et al. (2008) The role of local and systemic renin angiotensin system activation in a genetic model of sympathetic hyperactivity-induced heart failure in mice. Am J Physiol Regul Integr Comp Physiol 294: R26-32.
28. Kido M, Du L, Sullivan CC, Li X, Deutsch R, et al. (2005) Hypoxia-inducible factor 1-alpha reduces infarction and attenuates progression of cardiac dysfunction after myocardial infarction in the mouse. J Am Coll Cardiol 46: 2116-2124.
29. Alp PR, Newsholme EA, Zammit VA, (1976) Activities of citrate synthase and NAD+-linked and NADP+-linked isocitrate dehydrogenase in muscle from vertebrates and invertebrates. Biochem J 154: 689-700.
30. Cancherini DV, Queliconi BB, Kowaltowski AJ, (2007) Pharmacological and physiological stimuli do not promote Ca(2+)-sensitive K+ channel activity in isolated heart mitochondria. Cardiovasc Res 73: 720-728.
31. Tahara EB, Navarete FD, Kowaltowski AJ, (2009) Tissue-, substrate-, and site-specific characteristics of mitochondrial reactive oxygen species generation. Free Radic Biol Med 46: 1283-1297.
32. Murphy AN, Bredesen DE, Cortopassi G, Wang E, Fiskum G, (1996) Bcl-2 potentiates the maximal calcium uptake capacity of neural cell mitochondria. Proc Natl Acad Sci U S A 93: 9893-9898.
33. Vallentin A, Mochly-Rosen D, (2007) RBCK1, a protein kinase CbetaI (PKCbetaI)-interacting protein, regulates PKCbeta-dependent function. J Biol Chem 282: 1650-1657.
34. Glabe CG, (2004) Conformation-dependent antibodies target diseases of protein misfolding. Trends Biochem Sci 29: 542-547.
35. Antony JM, van Marle G, Opii W, Butterfield DA, Mallet F, et al. (2004) Human endogenous retrovirus glycoprotein-mediated induction of redox reactants causes oligodendrocyte death and demyelination. Nat Neurosci 7: 1088-1095.
36. Oliveira RS, Ferreira JC, Gomes ER, Paixao NA, Rolim NP, et al. (2009) Cardiac anti-remodelling effect of aerobic training is associated with a reduction in the calcineurin/NFAT signalling pathway in heart failure mice. J Physiol 587: 3899-3910.
37. Chen CH, Sun L, Mochly-Rosen D, (2010) Mitochondrial aldehyde dehydrogenase and cardiac diseases. Cardiovasc Res 88: 51-57.
38. Chen CH, Budas GR, Churchill EN, Disatnik MH, Hurley TD, et al. (2008) Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart. Science 321: 1493-1495.
39. Wang X, Robbins J, (2006) Heart failure and protein quality control. Circ Res 99: 1315-1328.
40. Schatz G, (2007) The magic garden. Annu Rev Biochem 76: 673-678.
41. Churchill EN, Ferreira JC, Brum PC, Szweda LI, Mochly-Rosen D, (2010) Ischaemic preconditioning improves proteasomal activity and increases the degradation of deltaPKC during reperfusion. Cardiovasc Res 85: 385-394.
42. Ferreira JC, Boer BN, Grinberg M, Brum PC, Mochly-Rosen D, (2012) Protein quality control disruption by PKCβII in heart failure; rescue by the selective PKCβII inhibitor, βIIV5-3. PLoS ONE 7: e33175.
43. Powell SR, Wang P, Katzeff H, Shringarpure R, Teoh C, et al. (2005) Oxidized and ubiquitinated proteins may predict recovery of postischemic cardiac function: essential role of the proteasome. Antioxid Redox Signal 7: 538-546.
44. da Cunha FM, Demasi M, Kowaltowski AJ, (2011) Aging and calorie restriction modulate yeast redox state, oxidized protein removal, and the ubiquitin-proteasome system. Free Radic Biol Med 51: 664-670.
45. Liberek K, Lewandowska A, Zietkiewicz S, (2008) Chaperones in control of protein disaggregation. Embo J 27: 328-335.
46. Shin JH, Kim SW, Lim CM, Jeong JY, Piao CS, et al. (2009) (B-crystallin suppresses oxidative stress-induced astrocyte apoptosis by inhibiting caspase 3 activation. Neurosci Res.
47. Chen Y, Liu Y, Dorn GW 2nd, (2011) Mitochondrial fusion is essential for organelle function and cardiac homeostasis. Circ Res 109: 1327-1331.
48. Li J, Horak KM, Su H, Sanbe A, Robbins J, et al. (2011) Enhancement of proteasomal function protects against cardiac proteinopathy and ischemia/reperfusion injury in mice. J Clin Invest 121: 3689-3700.
49. Ferrington DA, Kapphahn RJ, (2004) Catalytic site-specific inhibition of the 20S proteasome by 4-hydroxynonenal. FEBS Lett 578: 217-223.
50. Qi Z, He J, Su Y, He Q, Liu J, et al. (2011) Physical exercise regulates p53 activity targeting SCO2 and increases mitochondrial COX biogenesis in cardiac muscle with age. PLoS ONE 6: e21140.